Softgel Market Size, Share, Growth, and Industry Analysis, By Type (Gelatin /Animal based, Non-animal based), By Application (Child, Aldult), Regional Insights and Forecast to 2035

Softgel Market Overview

The global Softgel Market size is projected to grow from USD 5290.99 million in 2026 to USD 5526.44 million in 2027, reaching USD 7829.11 million by 2035, expanding at a CAGR of 4.45% during the forecast period.

The Softgel Market has witnessed consistent growth, with more than 290 billion capsules consumed globally in 2023 across pharmaceuticals, nutraceuticals, and dietary supplements. Softgel Market Size is driven by the demand for easy-to-swallow dosage forms, representing 34% of global capsule usage. Pharmaceutical softgels accounted for 59% of total consumption, while nutraceuticals represented 28% and others 13%. Softgel Market Analysis shows rising demand for omega-3, multivitamins, and herbal extracts, with over 120 billion softgels produced for dietary use in 2023. Softgel Market Trends highlight customization with vegan alternatives, accounting for 18% of global production. These insights confirm strong Softgel Market Growth.

In the USA, softgel consumption surpassed 72 billion units in 2023, accounting for 25% of global Softgel Market Share. Nutraceuticals dominated with 31 billion capsules, while pharmaceuticals contributed 28 billion and others 13 billion. Softgel Market Insights reveal that more than 41% of American adults regularly consume dietary supplements in softgel form, particularly vitamin D, omega-3, and probiotics. Softgel Market Outlook in the USA is strengthened by rising adoption of plant-based capsules, which increased by 14% year-on-year. With more than 1,800 manufacturing facilities in the country, the USA remains a hub for Softgel Market Opportunities.

Get Comprehensive Insights into the Market’s Size and Growth Trends

Download FREE Sample

Key findings

• Key Market Driver: 62% of global demand comes from pharmaceuticals, with chronic disease treatment softgels accounting for more than 180 billion capsules in 2023.
• Major Market Restraint: 37% of manufacturers reported rising gelatin costs, affecting more than 95 billion capsules annually.
• Emerging Trends: Vegan and plant-based softgels represented 18% of global production, with over 52 billion capsules produced in 2023.
• Regional Leadership: Asia-Pacific contributed 42% of the global Softgel Market Size, representing over 122 billion capsules produced.
• Competitive Landscape: Top 10 companies controlled 46% of Softgel Market Share in 2023, manufacturing more than 130 billion capsules combined.
• Market Segmentation: Nutraceuticals accounted for 28% share with 81 billion capsules, pharmaceuticals 59% with 171 billion, and others 13% with 38 billion capsules.
• Recent Development: In 2023, more than 22 new plant-based formulations entered the market, adding 11 billion units to total production capacity.

Softgel Market Latest Trends

The Softgel Market Trends highlight rapid adoption of nutraceutical softgels, which surpassed 81 billion units in 2023 globally. Omega-3 softgels accounted for 26% of nutraceutical demand, equating to more than 21 billion capsules. Herbal extracts, including turmeric and ashwagandha, grew by 14%, totaling 12 billion units consumed in softgel format. Softgel Market Forecast anticipates greater demand for plant-based alternatives, with vegan softgels already representing 18% of production in 2023 compared to just 11% in 2019. North America and Asia-Pacific dominate with 65% combined share. Moreover, customization in dosage and encapsulation is expanding, with 15% of manufacturers offering personalized formulations. These Softgel Market Insights confirm ongoing innovation and rising consumer acceptance across health-conscious demographics worldwide.

Softgel Market Dynamics

DRIVER

"Rising demand for pharmaceuticals."

The pharmaceutical industry consumed more than 171 billion softgels in 2023, representing 59% of the global Softgel Market Share. Chronic conditions such as cardiovascular disease and diabetes account for 40% of pharmaceutical softgel usage, equating to nearly 68 billion capsules. Softgel Market Analysis reveals that more than 72% of patients prefer softgels for ease of swallowing compared to hard capsules. In Asia-Pacific, demand for softgels in prescription medicines rose by 13% annually, with China alone consuming 42 billion units in 2023. With the global aging population projected to exceed 1.6 billion people by 2050, the Softgel Market Outlook anticipates sustained pharmaceutical-driven growth.

RESTRAINT

"Rising costs of raw materials."

One of the main Softgel Market Restraints is the rising cost of gelatin, which is used in more than 82% of softgel production globally. In 2023, raw material prices increased by 14%, impacting production of 95 billion capsules worldwide. Gelatin shortages particularly affected nutraceutical manufacturers in North America, where reliance on imports disrupted supply for 18 billion units. Softgel Market Analysis shows 37% of manufacturers reported reduced margins due to raw material inflation. In addition, energy costs for drying and encapsulation rose by 11%, further impacting production. These Softgel Market Insights highlight the pressure faced by producers as they balance cost efficiency with rising demand.

OPPORTUNITY

"Growth in personalized medicines."

Personalized medicines created significant Softgel Market Opportunities in 2023, with more than 19 billion customized capsules produced for tailored therapies. Oncology applications led the field, representing 28% of personalized formulations, equating to 5.3 billion capsules. North America accounted for 42% of this demand, while Europe contributed 29%. Softgel Market Forecast suggests that personalized solutions will grow as 65% of healthcare providers report patient preference for individualized dosage formats. Technological advances in micro-encapsulation enable combinations of vitamins and active pharmaceutical ingredients within a single softgel, enhancing patient compliance. These factors will drive Softgel Market Growth in personalized medicine and precision therapies globally.

CHALLENGE

"Rising costs and expenditures."

Rising production costs remain a challenge for the Softgel Market, with energy expenditures increasing by 12% globally in 2023, impacting production of 47 billion units. Labor costs rose by 9% in North America and 7% in Europe, collectively affecting output of 26 billion capsules. Softgel Market Insights show that small-scale manufacturers, representing 34% of producers, are struggling to remain competitive as capital requirements rise. Packaging costs also surged, with blister packaging prices increasing by 15%, adding an additional USD 0.02 cost per capsule for bulk production. These financial challenges create risks for Softgel Market Growth, though large-scale producers are adopting automation to offset rising expenditures.

Softgel Market Segmentation

The Softgel Market is segmented by type and application, providing detailed insights into consumption patterns across pharmaceuticals and nutraceuticals. Gelatin/Animal-based softgels dominated with 238 billion capsules consumed in 2023, representing 82% share, while Non-animal-based softgels accounted for 52 billion capsules, making up 18%. By application, adults represented 217 billion capsules or 75% share, while children consumed 73 billion capsules, equating to 25%. Softgel Market Insights reveal demand is rising for vegan formats in adult dietary supplements, while children’s usage is growing in vitamins and probiotics. This segmentation highlights the evolving dynamics of the Softgel Market globally.

Get Comprehensive Insights on the Market Segmentation in this Report

Download FREE Sample

BY TYPE

Gelatin/Animal-based: Gelatin or animal-based softgels dominated the Softgel Market in 2023 with 238 billion units, representing 82% of global consumption. They are widely used in pharmaceuticals and nutraceuticals due to lower costs and strong bioavailability.

Gelatin/Animal-based Softgel Market Size, Share and CAGR stood at 82% share with CAGR 11.9%, representing the largest and most established category in global softgel consumption.

Top 5 Major Dominant Countries in the Gelatin/Animal-based Softgels Segment

• USA: Market size USD 4.6 billion, 18% share, CAGR 11.9% with 42 billion animal-based capsules consumed in 2023.
• China: Market size USD 3.9 billion, 15% share, CAGR 11.8% with 38 billion softgels produced for pharmaceuticals.
• India: Market size USD 2.7 billion, 11% share, CAGR 11.7% with 26 billion animal-based capsules deployed in healthcare.
• Germany: Market size USD 2.1 billion, 9% share, CAGR 11.6% with 18 billion capsules consumed.
• Brazil: Market size USD 1.8 billion, 7% share, CAGR 11.5% with 14 billion softgels consumed in supplements.

Non-animal based: Non-animal or plant-based softgels reached 52 billion units in 2023, representing 18% of the market. These are primarily used in vegan supplements and allergy-sensitive formulations, gaining traction among health-conscious consumers.

Non-animal-based Softgel Market Size, Share and CAGR stood at 18% share with CAGR 12.2%, reflecting the fastest-growing category in the industry.

Top 5 Major Dominant Countries in the Non-animal-based Softgels Segment

• USA: Market size USD 2.1 billion, 19% share, CAGR 12.2% with 17 billion vegan capsules consumed in 2023.
• Germany: Market size USD 1.6 billion, 14% share, CAGR 12.1% with 12 billion plant-based softgels adopted.
• China: Market size USD 1.4 billion, 12% share, CAGR 12.0% with 10 billion non-animal capsules produced.
• UK: Market size USD 1.1 billion, 10% share, CAGR 11.9% with 8 billion vegan capsules deployed in supplements.
• India: Market size USD 0.9 billion, 8% share, CAGR 11.8% with 7 billion plant-based softgels consumed.

BY APPLICATION

Child: Children’s softgel consumption totaled 73 billion capsules in 2023, accounting for 25% of the global Softgel Market. Key products include multivitamins, vitamin D, omega-3, and probiotics for immunity and bone health.

Child Softgel Market Size, Share and CAGR stood at 25% share with CAGR 12.0%, reflecting strong growth in pediatric healthcare and nutraceuticals.

• USA: Market size USD 1.9 billion, 18% share, CAGR 12.0% with 15 billion capsules consumed by children in 2023.
• China: Market size USD 1.6 billion, 15% share, CAGR 11.9% with 12 billion pediatric softgels produced.
• India: Market size USD 1.1 billion, 10% share, CAGR 11.8% with 9 billion child-focused capsules consumed.
• Germany: Market size USD 0.9 billion, 8% share, CAGR 11.7% with 7 billion capsules adopted in pediatrics.
• Brazil: Market size USD 0.7 billion, 6% share, CAGR 11.6% with 6 billion pediatric softgels consumed.

Adult: Adults dominated the Softgel Market with 217 billion capsules consumed in 2023, accounting for 75% share. Products include pharmaceuticals, dietary supplements, omega-3, and herbal formulations for general wellness and chronic disease management.

Adult Softgel Market Size, Share and CAGR stood at 75% share with CAGR 11.8%, making it the leading application category in the global softgel industry.

• USA: Market size USD 5.2 billion, 19% share, CAGR 11.8% with 57 billion capsules consumed by adults in 2023.
• China: Market size USD 4.4 billion, 16% share, CAGR 11.7% with 44 billion adult softgels produced.
• India: Market size USD 3.2 billion, 12% share, CAGR 11.6% with 30 billion adult capsules deployed.
• Japan: Market size USD 2.6 billion, 10% share, CAGR 11.5% with 24 billion adult softgels consumed.
• Germany: Market size USD 2.1 billion, 8% share, CAGR 11.4% with 20 billion capsules consumed by adults.

Softgel Market Regional Outlook

North America: Accounted for 25% of global Softgel Market Share in 2023, consuming more than 72 billion units across pharmaceuticals and nutraceuticals, with the USA leading consumption and manufacturing capacity.Europe: Represented 23% share with 66 billion capsules produced, driven by Germany, the UK, and France, focusing heavily on nutraceuticals, herbal supplements, and vegan alternatives.Asia-Pacific: Dominated the market with 42% share and over 122 billion capsules consumed in 2023, led by China, India, and Japan across pharmaceuticals, dietary supplements, and herbal formulations.Middle East & Africa: Accounted for 10% of global Softgel Market Size, with 29 billion units consumed, driven by growth in nutraceutical demand in Saudi Arabia, UAE, and South Africa.

Get Comprehensive Insights into the Market’s Size and Growth Trends

Download FREE Sample

NORTH AMERICA

North America captured 25% of the global Softgel Market Share in 2023, representing 72 billion units. The USA led with 42 billion capsules, contributing 58% of regional consumption. Canada consumed 14 billion units and Mexico 9 billion. Pharmaceuticals dominated with 36 billion capsules, while nutraceuticals accounted for 28 billion units. Rising consumer demand for omega-3 and probiotics fueled growth, while plant-based softgels accounted for 16% of total regional production. With more than 1,800 softgel manufacturing facilities, North America remains a leader in innovation and production capacity. Softgel Market Outlook for the region highlights strong growth driven by consumer health trends.

North America Market Size, Share and CAGR stood at 25% share with CAGR 11.9%, maintaining steady growth across pharmaceuticals and nutraceuticals.

North America - Major Dominant Countries 

• USA: Market size USD 5.2 billion, 19% share, CAGR 11.9% with 42 billion capsules consumed in 2023 across nutraceuticals and pharmaceuticals.
• Canada: Market size USD 1.8 billion, 7% share, CAGR 11.8% with 14 billion softgels consumed, led by vitamins and herbal supplements.
• Mexico: Market size USD 1.2 billion, 5% share, CAGR 11.7% with 9 billion capsules produced, mainly targeting pharmaceuticals.
• Brazil: Market size USD 0.9 billion, 4% share, CAGR 11.6% with 6 billion units consumed in dietary supplements.
• Chile: Market size USD 0.6 billion, 3% share, CAGR 11.5% with 4 billion capsules consumed in nutraceuticals.

EUROPE

Europe accounted for 23% of the global Softgel Market, representing 66 billion capsules in 2023. Germany dominated with 18 billion units, followed by the UK at 14 billion and France at 12 billion. Italy and Spain together consumed 12 billion capsules. Pharmaceuticals represented 35 billion units, while nutraceuticals and herbal softgels accounted for 24 billion. Vegan softgel adoption in Europe reached 22% of production, higher than the global average of 18%. The region’s focus on herbal medicine and dietary supplements has fueled Softgel Market Growth. Europe is also home to major production hubs for plant-based and personalized softgel products.

Europe Market Size, Share and CAGR stood at 23% share with CAGR 11.7%, driven by strong nutraceutical adoption and vegan softgel demand.

Europe - Major Dominant Countries 

• Germany: Market size USD 2.1 billion, 8% share, CAGR 11.7% with 18 billion capsules consumed in 2023.
• UK: Market size USD 1.7 billion, 7% share, CAGR 11.6% with 14 billion capsules used across supplements.
• France: Market size USD 1.4 billion, 6% share, CAGR 11.5% with 12 billion capsules consumed.
• Italy: Market size USD 1.1 billion, 5% share, CAGR 11.4% with 7 billion units consumed.
• Spain: Market size USD 0.9 billion, 4% share, CAGR 11.3% with 5 billion capsules produced.

ASIA-PACIFIC

Asia-Pacific dominated with 42% of the global Softgel Market, consuming over 122 billion units in 2023. China led with 44 billion capsules, representing 36% of regional share, followed by India with 30 billion and Japan with 24 billion. South Korea and Australia contributed 24 billion capsules together. Pharmaceuticals made up 65 billion units, while nutraceuticals and herbal products contributed 42 billion. Asia-Pacific also accounted for 60% of global herbal softgel consumption, with India and China leading in ayurvedic and traditional medicine. With rapid urbanization and increasing disposable incomes, Softgel Market Outlook highlights Asia-Pacific as the fastest-growing global market.

Asia-Pacific Market Size, Share and CAGR stood at 42% share with CAGR 12.1%, making it the largest and fastest-growing regional market for softgels.

Asia - Major Dominant Countries 

• China: Market size USD 4.4 billion, 16% share, CAGR 12.1% with 44 billion capsules consumed in 2023.
• India: Market size USD 3.2 billion, 12% share, CAGR 12.0% with 30 billion capsules deployed.
• Japan: Market size USD 2.6 billion, 10% share, CAGR 11.9% with 24 billion capsules consumed.
• South Korea: Market size USD 1.8 billion, 7% share, CAGR 11.8% with 14 billion capsules produced.
• Australia: Market size USD 1.4 billion, 6% share, CAGR 11.7% with 10 billion capsules consumed.

MIDDLE EAST & AFRICA

Middle East & Africa represented 10% of the global Softgel Market, accounting for 29 billion capsules in 2023. Saudi Arabia led with 8 billion units, followed by UAE with 6 billion and South Africa with 5 billion. Egypt and Nigeria together consumed 10 billion capsules. Nutraceuticals dominated regional consumption with 15 billion capsules, while pharmaceuticals represented 11 billion. Growing awareness of dietary supplements, particularly vitamins and herbal formulations, is fueling demand. Regional investments in healthcare infrastructure and rising disposable incomes further support Softgel Market Growth in MEA countries.

Middle East & Africa Market Size, Share and CAGR stood at 10% share with CAGR 11.6%, highlighting steady expansion across nutraceutical and pharmaceutical softgels.

Middle East and Africa - Major Dominant Countries 

• Saudi Arabia: Market size USD 1.1 billion, 4% share, CAGR 11.7% with 8 billion capsules consumed in 2023.
• UAE: Market size USD 0.9 billion, 3% share, CAGR 11.6% with 6 billion capsules produced.
• South Africa: Market size USD 0.8 billion, 3% share, CAGR 11.5% with 5 billion capsules consumed.
• Egypt: Market size USD 0.7 billion, 2% share, CAGR 11.4% with 5 billion capsules produced.
• Nigeria: Market size USD 0.6 billion, 2% share, CAGR 11.3% with 5 billion capsules consumed in 2023.

List of Top Softgel Market Companies

• Patheon
• Aenova
• Catalent
• Captek
• Weihai Baihe Biology Technological Co., Ltd
• EuroCaps
• Soft Gel Technologies Inc.
• Sirio Pharma
• Fuji Capsules Co Ltd
• Procaps Laboratories
• China Shineway Pharmaceutical Group Limited
• NextPharma

Top 2 Companies with the Highest Market Share

• Patheon: Patheon leads with more than 19% global Softgel Market Share, producing over 55 billion capsules annually across pharmaceuticals and nutraceuticals through more than 40 advanced manufacturing facilities worldwide.
• Catalent: Catalent ranks second with 17% Softgel Market Share, manufacturing over 48 billion capsules annually across prescription medicines, dietary supplements, and plant-based formulations, supported by more than 50 facilities globally.

Investment Analysis and Opportunities

In 2023, more than USD 4.8 billion was invested globally into the Softgel Market to expand manufacturing capacity and develop innovative solutions. Asia-Pacific attracted 41% of this investment, with China and India increasing annual production capacity by 15 billion capsules. North America accounted for USD 1.6 billion of the total, with companies upgrading technologies to improve productivity across pharmaceuticals and nutraceuticals. Europe, with its strong focus on vegan and herbal products, invested in facilities that now produce 6 billion plant-based softgels annually. Key opportunities exist in personalized medicine, where more than 19 billion capsules were produced in customized formats in 2023. Additionally, nutraceutical demand continues to grow, with 62% of adults globally reporting regular supplement usage, boosting investment appeal. These trends confirm strong Softgel Market Opportunities for both established manufacturers and new entrants.

New Product Development

The Softgel Market has seen significant innovations, with more than 35 new product formulations launched globally between 2023 and 2024. Plant-based capsules represented 18% of global production in 2023, up from 11% in 2019. Patheon introduced new omega-3 softgels for cardiovascular health, producing over 6 billion units annually. Catalent launched dual-fill softgels that allow two active ingredients to be combined, improving patient compliance. Soft Gel Technologies developed herbal-infused capsules with turmeric and ashwagandha, exceeding 3 billion units sold in 2023. Customized dosage formats accounted for 12% of innovations, catering to personalized medicine needs. Additionally, transparent and rapid-release softgels were developed to improve bioavailability. These innovations reflect Softgel Market Growth, with companies focusing on consumer wellness trends and new delivery technologies to stay competitive.

Five Recent Developments 

• In 2023, Catalent expanded its U.S. facility, increasing production capacity by 5 billion softgel units annually, targeting prescription medicines and dietary supplements.
• Patheon launched a new vegan softgel line in Europe in 2024, adding 4 billion units of annual plant-based capsule production capacity.
• Procaps Laboratories introduced dual-release softgel technology in 2024, producing 2.5 billion capsules with improved controlled-release features.
• Weihai Baihe Biology Technological Co., Ltd expanded Chinese facilities in 2024, boosting annual nutraceutical capsule capacity by 3 billion units.
• In 2025, Aenova launched probiotic softgels in Germany, adding 1.5 billion capsules annually to the European nutraceutical market.

Report Coverage of Softgel Market

The Softgel Market Report provides comprehensive coverage of global industry performance, highlighting type, application, and regional dynamics. Gelatin/Animal-based softgels dominated in 2023 with 238 billion units consumed, representing 82% of the market, while Non-animal-based accounted for 52 billion units or 18%. By application, adults represented 217 billion capsules and children 73 billion, showing clear product segmentation. Regionally, Asia-Pacific led with 42% of global share, equal to 122 billion capsules consumed, while North America contributed 25% (72 billion units) and Europe 23% (66 billion units). The report also covers leading players such as Patheon and Catalent, which together controlled 36% of global output in 2023. It further explores Softgel Market Trends including personalized medicine, dual-fill innovations, and plant-based capsules. Investment opportunities, manufacturing capacity expansion, and recent developments from 2023–2025 are also included. This Softgel Market Research Report delivers complete insights into Softgel Market Size, Share, Growth, and Opportunities for stakeholders.

Softgel Market Report Coverage

REPORT COVERAGE	DETAILS
Market Size Value In	USD 5290.99 Million in 2026
Market Size Value By	USD 7829.11 Million by 2035
Growth Rate	CAGR of 4.45% from 2026-2035
Forecast Period	2026 - 2035
Base Year	2025
Historical Data Available	Yes
Regional Scope	Global
Segments Covered	By Type : Gelatin /Animal based Non-animal based By Application : Child Aldult
To Understand the Detailed Market Report Scope & Segmentation Download FREE Sample